Prevalence and Risk Factors for Coxiella Burnetii Seropositivity (Q Fever) Among Adults in Western France
NCT ID: NCT03334019
Last Updated: 2018-05-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
559 participants
OBSERVATIONAL
2017-11-06
2019-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In Western France, Q fever is endemic in cattle herds. To improve human zoonotic disease surveillance, the investigators will conduct a population based study in this area.
The aims of the study are:
1. To assess seroprevalence of Coxiella burnetii infection among general population, farmers and veterinarians in Western France
2. To identify risk factors for Coxiella burnetii seropositivity in these populations
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevention of Carbapenemase-producing Enterobacteriaceae Epidemics: Evaluation of a Simplified Contact Screening Policy (CADECO)
NCT06839911
Prevalence of Digestive Carriage of Integrons
NCT01985217
Vascular Infections Caused by Coxiella Burnetii
NCT07305402
Does the National Health Insurance Card Allow us to Predict Antibiotic Resistance?
NCT02292160
Exposure to Antibiotics and Incidence of Bacteraemia Caused by Resistant Bacteria
NCT04065750
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* blood donors at blood donation organizations (general population)
* beef and dairy cattle farmers
* veterinarians involved in a rural practice
All the participants in the study will provide a blood sample and will fill in a questionnaire.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
subjects
Data collected on general population, farmers and veterinarians though questionnaires and blood samples.
blood test
Data collected on general population, farmers and veterinarians though questionnaires and blood samples.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
blood test
Data collected on general population, farmers and veterinarians though questionnaires and blood samples.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be 18 years old and over
* Be able to speak French
Exclusion Criteria
* Contraindication for drawing blood
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ONIRIS
INDUSTRY
Nantes University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Leila Moret, PU-PH
Role: PRINCIPAL_INVESTIGATOR
Nantes University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Nantes
Nantes, , France
CHU de Nantes
Nantes, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC16_0420
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.